eyeQ: time to consider buying South Korea once again
Experts at eyeQ use AI and their own smart machine to analyse macro conditions and generate actionable trading signals. Here’s what it says following the tech sell-off.
10th November 2026 09:27
by Huw Roberts from eyeQ

An electronic display board shows closing stock indices at the Korea Exchange in Seoul on Friday. Photo: Chris Jung/NurPhoto via Getty Images.
“Our signals are crafted through macro-valuation, trend analysis, and meticulous back-testing. This combination ensures a comprehensive evaluation of an asset's value, market conditions, and historical performance.” eyeQ
- Discover: eyeQ analysis explained | eyeQ: our smart machine in action | Glossary
KOSPI (Korea Composite Stock Price Index)
The following eyeQ analysis focuses on the South Korea equity index, the Korea Composite Stock Price Index or KOSPI. interactive investor provides several options for investors looking to gain exposure to South Korea, including Barings Korea I GBP Acc (B9M3RQ4), iShares MSCI Korea ETF USD Dist GBP (LSE:IKOR), and Franklin FTSE Korea UCITS ETF GBP (LSE:FLRK).
South Korean equities have been a popular trade in 2026. The Korean equity market is dominated by two stocks - Samsung Electronics Co Ltd DR (LSE:SMSN) (22% of the KOSPI index) and SK hynix Inc ADR (NASDAQ:SKHY) (21% weight). Both are artificial intelligence (AI) plays, so were beneficiaries during the bull run;,but equally both have suffered in this de-rating of the AI revolution more recently.
And it’s the recent correction that has now popped up on eyeQ’s radar. The macro story is as follows:
- For most of 2025, the Kospi was very much a macro trade
- However, it fell out of a macro regime in March this year. During that time, macro wasn’t doing a good job of explaining price moves. In the chart, you can see eyeQ’s model (in orange) lagged the move in the index itself (black)
- But macro relevance crossed back above our 65% threshold at the end of September and today sits at 85%. The KOSPI is once again being driven by macro forces
- eyeQ model value fell 30% between July andf September. But since 1 October our model value has bounced 12.5%. Put another way, macro was a big drag on South Korean stocks over the summer but has since stabilised
- The contrast between stable macro conditions and a falling market means the KOSPI now sits 35% cheap on our metrics.
From an exclusively macro perspective, the conclusion is that this latest sell-off has gone too far and it could be time to re-consider scaling into exposure to South Korea once again.

Source: eyeQ. Past performance is not a guide to future performance.
Useful terminology:
Model value
Where our smart machine calculates that any stock market index, single stock or exchange-traded fund (ETF) should be priced (the fair value) given the overall macroeconomic environment.
Model (macro) relevance
How confident we are in the model value. The higher the number the better! Above 65% means the macro environment is critical, so any valuation signals carry strong weight. Below 65%, we deem that something other than macro is driving the price.
Fair Value Gap (FVG)
The difference between our model value (fair value) and where the price currently is. A positive Fair Value Gap means the security is above the model value, which we refer to as “rich”. A negative FVG means that it's cheap. The bigger the FVG, the bigger the dislocation and therefore a better entry level for trades.
Long Term model
This model looks at share prices over the last 12 months, captures the company’s relationship with growth, inflation, currency shifts, central bank policy etc and calculates our key results - model value, model relevance, Fair Value Gap.
These third-party research articles are provided by eyeQ (Quant Insight). interactive investor does not make any representation as to the completeness, accuracy or timeliness of the information provided, nor do we accept any liability for any losses, costs, liabilities or expenses that may arise directly or indirectly from your use of, or reliance on, the information (except where we have acted negligently, fraudulently or in wilful default in relation to the production or distribution of the information).
The value of your investments may go down as well as up. You may not get back all the money that you invest.
Equity research is provided for information purposes only. Neither eyeQ (Quant Insight) nor interactive investor have considered your personal circumstances, and the information provided should not be considered a personal recommendation. If you are in any doubt as to the action you should take, please consult an authorised financial adviser.
Disclosure
We use a combination of fundamental and technical analysis in forming our view as to the valuation and prospects of an investment. Where relevant we have set out those particular matters we think are important in the above article, but further detail can be found here.
Please note that our article on this investment should not be considered to be a regular publication.
Details of all recommendations issued by ii during the previous 12-month period can be found here.
ii adheres to a strict code of conduct. Contributors may hold shares or have other interests in companies included in these portfolios, which could create a conflict of interests. Contributors intending to write about any financial instruments in which they have an interest are required to disclose such interest to ii and in the article itself. ii will at all times consider whether such interest impairs the objectivity of the recommendation.
In addition, individuals involved in the production of investment articles are subject to a personal account dealing restriction, which prevents them from placing a transaction in the specified instrument(s) for a period before and for five working days after such publication. This is to avoid personal interests conflicting with the interests of the recipients of those investment articles.